Cannabis Testing Market Positive long-term growth outlook 2018-2026
Cannabis testing is
done for various purpose such as finding concentration of active
ingredient (cannabinoids, terpene), which determines the medical
potency of the cannabis. It is also tested for determining various
other ingredient in given sample. For instance, to determine the
pesticide residue content in the given sample that undermines the
purity and efficacy. Cannabis testing also involves determination of
contaminants such as fungi and bacteria (mycotoxins), which could
causes serious pulmonary infections if administered unchecked.
Key players
operating in the cannabis testing market include Shimadzu
Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific,
Inc., PerkinElmer, Inc., Millipore Sigma, AB SCIEX LLC, Cannabix
Technologies, Inc., Waters Corporation, Steep Hill Labs, Inc.,
CannaSafe Analytics, Accelerated Technology Laboratories, Inc.,
LabLynx, Inc., SC Laboratories Inc., GenTech Scientific, Pharm Labs,
LLC, and Digipath Labs, Inc.
Request For
Sample Copy of This Research Report:
Overall cannabis
testing process involves sample and column preparation,
identification of analyte, determining concentration, and separating
the analyte. Various analytical techniques majorly used to test the
cannabis are Liquid Chromatography (LC) / High Performance Liquid
Chromatography (HPLC), Gas Chromatography (GC), Thin Layer
Chromatography (TLC), ELISA kits, and Polymerase Chain Reaction
(PCR). Cannabis testing products also involves breathe analyzer and
other instruments to check concentration of tetrahydrocannabinol when
consumed illegally. Tetrahydrocannabinol is psychoactive ingredient.
The global cannabis
testing market size was valued at US$ 926.3 million in 2017, and is
expected to witness a CAGR of 13.2% over the forecast period (2018 –
2026).
Legalization of
cannabis for medicinal and recreational activity to drive growth of
the cannabis testing market
Increasing approval
of medicinal cannabis products along with extensive research and
development activities in the medical cannabis market are expected to
support growth of the cannabis testing market.
Cannabis testing
market is projected to witness positive growth during the forecast
period, owing to the requirement of desired active ingredient
detection and undesired trace elements (mycotoxins and trace metals)
before utilizing cannabis product for medicinal and recreational
purpose. Increased trend of using cannabis for recreational purpose
would be another major impetus for simultaneous rise in cannabis
testing market.
In 2012, only two
states in the U.S. had legalized recreational use of cannabis however
by 2017, seven more states legalized recreational use of cannabis. In
January 2018, use of cannabis for recreational purpose initiated in
California which resulted in tourist attraction in California and in
turn it also doubled the cannabis cultivation assessing business
opportunity.
Increased approval
for cannabis-based drugs and new product launches for cannabis
testing are expected to propel growth of the cannabis testing market
Various cannabis
manufacturer across globe are focused on introducing the cannabis
products to target various disease, which in turn is expected to
promote application of cannabis testing instruments, as this products
need to be approved from the health regulatory bodies for their
efficacy and purity. For instance, in May 2018, the U.S Food and Drug
Administration (FDA) approved the medication, called Epidiolex
manufactured by GW Pharmaceuticals to treat two rare forms of
epilepsy caused by Lennox-Gastaut and Dravet syndromes in patients
two years and older.
In July 2016, Insys
Therapeutics, Inc. received U.S.FDA approval for dronabinol oral
solution- Syndros, which is an orally administered liquid formulation
of cannabinoid dronabinol. The Syndros is indicated for treatment of
anorexia associated with weight loss among patients suffering from
AIDS and patients suffering from cancer chemotherapy-induced nausea
and vomiting.
Companies are
launching innovative, precise, and efficient analytical platform for
cannabis testing, which is expected to fuel market growth. For
instance, Agilent Technologies Inc. in 2017, introduced a
high-resolution, accurate gas chromatography mass system named as
Agilent 7250 GC/Q-TOF system, which combines gas chromatography and
quadrupole time-of-flight mass spectrometry with a Low Energy
Electron Ionization source enabling high exploration of unknown
chemical samples.
High cost of
analytical instruments for testing cannabis is one of the factors
restraining growth of the market. Furthermore, there are no standards
for various residue and unwanted material in cannabis such as
pesticide residue, heavy metal, and mycotoxin, which results into
inauthenticity of test results given by different cannabis testing
laboratories.
Click To Read More On Cannabis Testing Market
About Coherent
Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment